ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

4 links2 made here, not in the record5 judgments2 judges (our rules as one)0 record changes seen
Claude Opus 5.5Our rulesMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07003074A Clinical Study of TQB2102Versus Docetaxel PlusTrastuzumab and Pertuzumabin the Treatment of HER2Positive Recurrent orMetastatic Breast CancerChia Tai Tianqing PharmaceuticPhase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionDRUGSAnti-HER2/Topoisomerase I I…Entry “TQB2102 for Injection”, read b…›Nov 18 · Our role rule · TestedTestedTrastuzumabMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · ComparatorComparatorPertuzumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Trastuzumab

Made here1 judgment on this link
NCT07003074gives it, found by reading the recordTrastuzumabDefined by Claude Opus 5.5Nov 2, 2026, 3:40 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2Trastuzumabmade hereClaude Opus 5.5ComparatorCurrent
Nov 3Pertuzumabmade hereClaude Opus 5.5ComparatorCurrent
Nov 14Breast NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 18Anti-HER2/Topoisomerase I Inhibitor ADC TQB2102Our role ruleTestedCurrent
As of nowBreast NeoplasmsOur main-condition rule (R9)Main conditionCurrent